The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Infantile Hemangioma

A common benign vascular tumor appearing in the first weeks of life in infants.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Infantile Hemangioma?

Infantile hemangioma is a benign vascular tumor that appears in the first weeks after birth, grows rapidly during the first year of life and slowly regresses over years.

Superficial (bright red 'strawberry' lesion), deep (bluish subcutaneous swelling) and mixed types exist. Most heal without complications; however, locations such as the eye, airway and liver can lead to significant problems.

In recent years, propranolol therapy has allowed safe arrest of growth and acceleration of regression.

Symptoms

Bright red superficial lesion
Bluish subcutaneous swelling (deep type)
Rapid growth (first 3-6 months)
Subsequent fading and shrinking
Ulceration and bleeding (some cases)
Visual problems with eyelid involvement
Respiratory difficulty with airway involvement

Risk Factors

Prematurity and low birth weight
Female sex
Multiple pregnancy
Caucasian race
Placental abnormalities
Advanced maternal age
Amniocentesis during pregnancy

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When rapidly growing red lesions appear
  • If located in the eye, lip, nose or genital area
  • If lesions develop ulceration and bleeding
  • If swelling affects feeding or breathing
  • When more than 5 hemangiomas are present (screening for visceral involvement)

Treatment Methods

01
Observation (uncomplicated cases)
02
Topical or systemic propranolol
03
Topical timolol
04
Systemic corticosteroid (selected cases)
05
Pulsed-dye laser (ulceration and residual telangiectasia)
06
Multidisciplinary evaluation (ophthalmology, ENT)

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.